FDA May Authorize Second COVID Booster For People Over 50

The video discusses the potential authorization of a second COVID-19 booster shot for people over 50, amid rising infection rates and the emergence of the Omicron subvariant BA2. The FDA may authorize the booster soon, with the CDC providing guidance on its implementation. Concerns include funding issues affecting pandemic response and waning immunity in the elderly. The BA2 variant is not expected to cause a significant wave but serves as a warning for future variants.

What are the implications of waning immunity in the elderly population concerning COVID-19?

What role does the CDC play after the FDA's expected authorization of the fourth COVID shot?